Mitrate 60xl (Isosorbide Mononitrate)

Isosorbide Mononitrate, the active ingredient in Mitrate 60xl, is a nitrate presented as an oral tablet for systemic use. It is employed in the prophylaxis and treatment of angina pectoris, helping to reduce the frequency of chest pain episodes in adults with chronic stable angina.

GNH USA supplies Mitrate 60xl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and other healthcare institutions worldwide, ensuring quality and regulatory compliance across all markets, through reliable logistics and timely delivery.

Isosorbide Mononitrate is a nitrate used in the management of coronary artery disease‑related angina. - Prophylaxis of angina pectoris: reduces the frequency of chest pain episodes. - Treatment of chronic stable angina: improves exercise tolerance and reduces symptom burden. - Management of coronary artery disease symptoms: alleviates myocardial oxygen demand and improves quality of life.

Isosorbide Mononitrate may cause a range of adverse reactions.

Common Side Effects: - Headache: throbbing pain often occurring shortly after dosing. - Dizziness or light‑headedness: related to blood pressure reduction. - Flushing: warm sensation and reddening of the skin. - Nausea or gastrointestinal discomfort. - Palpitations: awareness of heartbeat acceleration. - Hypotension: mild drop in blood pressure, especially on standing.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall requiring medical attention. - Syncope: sudden loss of consciousness. - Myocardial infarction: rare but possible in susceptible patients. - Life‑threatening arrhythmias: irregular heart rhythms. - Anaphylactic reaction: severe allergic response. - Methemoglobinemia: rare disorder affecting oxygen transport.

Before prescribing Isosorbide Mononitrate, clinicians should consider several safety aspects. - Assess cardiovascular status: evaluate blood pressure and heart function prior to initiation. - Avoid concurrent use with phosphodiesterase‑5 inhibitors: risk of profound hypotension. - Monitor for tolerance development: efficacy may diminish with prolonged use. - Adjust dose in renal impairment: use caution in severe renal dysfunction. - Pregnancy and lactation: safety not established; use only if benefit outweighs risk. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

Isosorbide Mononitrate can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Sildenafil and other PDE‑5 inhibitors: may cause severe hypotension. - Other nitrates (e.g., nitroglycerin, isosorbide dinitrate): additive vasodilatory effect leading to dangerous blood pressure drop. - Potent antihypertensive agents (e.g., ACE inhibitors, beta‑blockers): may enhance hypotensive effect.

Moderate Interactions (Monitor Closely): - Azole antifungals (e.g., ketoconazole): may increase plasma levels of isosorbide mononitrate. - Macrolide antibiotics (e.g., erythromycin): may raise drug exposure. - Diuretics: can potentiate hypotension, especially when initiating therapy. - Alcohol: may augment vasodilatory effects and increase dizziness.